Elucidation and inhibition of the biosynthetic pathway to the anthrax stealth siderophore petrobactin
炭疽隐形铁载体 Petrobactin 生物合成途径的阐明和抑制
基本信息
- 批准号:BB/F013760/1
- 负责人:
- 金额:$ 49.11万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2008
- 资助国家:英国
- 起止时间:2008 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Bacillus anthracis is the bacterium that causes anthrax, a frequently fatal disease of animals and humans. It has attracted considerable attention in recent years because of the potential to use its spores as a biological terror agent. While anthrax can be treated using currently available antibiotics e.g. ciprofloxacin, Bacillus anthracis could be genetically engineered to make it resistant to all currently available antibiotics. The bioterrorism threat posed by such genetically engineered strains would be considerable and there is thus a need to develop new antibiotics that are active against B. anthracis. Iron is an essential element for the proliferation of virtually all bacteria including B. anthracis. As a consequence, the systems used by infectious bacteria to acquire iron from their hosts represent potential targets for the development of therapeutic agents. Siderophores are metabolites excreted by most bacteria that bind tightly to ferric iron. Within and between mammalian cells ferric iron is tightly bound by proteins (e.g. transferrin and lactoferrin). Siderophores produced by infectious bacteria are able to remove the ferric iron from these proteins and transport it into the bacterial cell. For several infectious bacteria, inhibition of the pathways they use for siderophore synthesis is known to strongly attenuate or abrogate their ability to cause infection. B. anthracis has been shown to excrete two siderophores called bacillibactin and petrobactin. While bacillibactin is not required for B. anthracis growth in mouse models of infection, petrobactin plays a significant role. This has been attributed to the ability of petrobactin, but not bacillibactin, to avoid the mammalian immune system, suggesting that small molecules designed to inhibit the enzymes catalysing assembly of petrobactin may be effective antibiotics against B. anthracis. To design such inhibitors a fundamental understanding at the molecular level of how these enzymes catalyse the assembly of petrobactin is required. Genetic studies have shown that the petrobactin biosynthetic pathway is a unique hybrid of two well-known pathways for siderophore biosynthesis, one of which is almost completely unexplored at the molecular level. Biochemical studies have begun to reveal the molecular details of petrobactin biosynthesis and have led to the discovery of novel and interesting enzymes with potential applications in the production of valuable building blocks for the synthesis of drug candidates and other fine chemicals. This proposal aims to investigate the catalytic properties of a key enzyme in petrobactin synthesis in detail, as well as design, synthesise and test the first inhibitors of this enzyme family. It also aims to investigate the catalytic properties of two other important enzymes involved in petrobactin assembly. This will clarify the pathway used by B. anthracis for petrobactin synthesis, which at present is unclear.
炭疽杆菌是引起炭疽病的细菌,炭疽病是一种经常致命的动物和人类疾病。近年来,由于其孢子有可能被用作生物恐怖剂,因此引起了相当大的关注。虽然炭疽可以使用目前可用的抗生素(如环丙沙星)治疗,但炭疽杆菌可以通过基因工程使其对所有目前可用的抗生素具有抗性。这种基因工程菌株造成的生物恐怖主义威胁是相当大的,因此需要开发对B有活性的新抗生素。炭疽病铁是几乎所有细菌(包括B)增殖的必需元素。炭疽病因此,感染性细菌从其宿主获得铁的系统代表了开发治疗剂的潜在目标。铁载体是大多数细菌分泌的代谢产物,与三价铁紧密结合。在哺乳动物细胞内和哺乳动物细胞之间,三价铁与蛋白质(例如转铁蛋白和乳铁蛋白)紧密结合。由感染性细菌产生的铁载体能够从这些蛋白质中去除三价铁并将其运输到细菌细胞中。对于几种感染性细菌,已知抑制它们用于铁载体合成的途径会强烈减弱或消除它们引起感染的能力。B。炭疽菌已显示分泌两种铁载体,称为杆菌素和岩杆菌素。而B不需要杆菌素。在小鼠炭疽菌感染模型的生长中,petrobactin起着显著的作用。这归因于petrobactin而不是bacillibactin避开哺乳动物免疫系统的能力,表明设计用于抑制催化petrobactin组装的酶的小分子可能是针对B的有效抗生素。炭疽病为了设计这样的抑制剂,需要在分子水平上对这些酶如何催化petrobactin的组装有基本的理解。遗传学研究表明,petrobactin生物合成途径是一个独特的杂交两个众所周知的铁载体生物合成途径,其中之一是几乎完全未在分子水平上探索。生物化学研究已经开始揭示petrobactin生物合成的分子细节,并导致发现了新的和有趣的酶,其在生产用于合成候选药物和其他精细化学品的有价值的构件中具有潜在的应用。本论文旨在详细研究petrobactin合成中一个关键酶的催化特性,并设计、合成和测试该酶家族的第一个抑制剂。它还旨在研究参与petrobactin组装的另外两种重要酶的催化特性。这将阐明B使用的途径。炭疽菌用于petrobactin合成,目前尚不清楚。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Functional Molecules from Natural Sources
天然来源的功能分子
- DOI:
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Wrigley, Stephen K.;Thomas, Robert;Nicholson, Neville;Bedford, Colin
- 通讯作者:Bedford, Colin
AcsD catalyzes enantioselective citrate desymmetrization in siderophore biosynthesis.
- DOI:10.1038/nchembio.145
- 发表时间:2009-03
- 期刊:
- 影响因子:14.8
- 作者:Schmelz, Stefan;Kadi, Nadia;McMahon, Stephen A.;Song, Lijiang;Oves-Costales, Daniel;Oke, Muse;Liu, Huanting;Johnson, Kenneth A.;Carter, Lester G.;Botting, Catherine H.;White, Malcolm F.;Challis, Gregory L.;Naismith, James H.
- 通讯作者:Naismith, James H.
Functional and Structural Analysis of the Siderophore Synthetase AsbB through Reconstitution of the Petrobactin Biosynthetic Pathway from Bacillus anthracis
- DOI:10.1074/jbc.m112.359349
- 发表时间:2012-05-04
- 期刊:
- 影响因子:4.8
- 作者:Nusca, Tyler D.;Kim, Youngchang;Sherman, David H.
- 通讯作者:Sherman, David H.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory Challis其他文献
Gregory Challis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory Challis', 18)}}的其他基金
GEN2NCE - a synthetic biology platform for natural product discovery
GEN2NCE - 用于天然产物发现的合成生物学平台
- 批准号:
BB/T017163/1 - 财政年份:2020
- 资助金额:
$ 49.11万 - 项目类别:
Research Grant
Gen2NCE - a genomics-driven platform for novel bioactive natural product discovery
Gen2NCE - 基因组学驱动的新型生物活性天然产物发现平台
- 批准号:
BB/T010053/1 - 财政年份:2019
- 资助金额:
$ 49.11万 - 项目类别:
Research Grant
Establishing the Efficacy, Safety and Persistence of biopesticides based on naturally occurring beneficial bacteria
确定基于天然有益细菌的生物农药的功效、安全性和持久性
- 批准号:
BB/S008020/1 - 财政年份:2019
- 资助金额:
$ 49.11万 - 项目类别:
Research Grant
EVOBIOTIC: Capturing the natural antibiotic'ome: Developing Nature's EVOlved AntiBIOTIC
EVOBIOTIC:捕获天然抗生素组:开发 Natures EVOlved AntiBIOTIC
- 批准号:
MR/N501839/1 - 财政年份:2015
- 资助金额:
$ 49.11万 - 项目类别:
Research Grant
Exploitation of Burkholderia bacteria as novel antibiotic producers using a genome mining approach
使用基因组挖掘方法将伯克霍尔德氏菌开发为新型抗生素生产者
- 批准号:
BB/L023342/1 - 财政年份:2014
- 资助金额:
$ 49.11万 - 项目类别:
Research Grant
Exploiting natural product assembly line genomics and synthetic biology for discovery and optimisation of novel agrochemicals
利用天然产物装配线基因组学和合成生物学来发现和优化新型农用化学品
- 批准号:
BB/K002341/1 - 财政年份:2013
- 资助金额:
$ 49.11万 - 项目类别:
Research Grant
Exploiting microbial genomics and synthetic biology for discovery of novel antibiotics
利用微生物基因组学和合成生物学发现新型抗生素
- 批准号:
BB/L010852/1 - 财政年份:2013
- 资助金额:
$ 49.11万 - 项目类别:
Research Grant
Elucidating and exploiting cytochrome P450 TxtE-catalysed tryptophan nitration in thaxtomin phytotoxin biosynthesis
阐明和利用 thaxtomin 植物毒素生物合成中细胞色素 P450 TxtE 催化的色氨酸硝化
- 批准号:
BB/H006281/1 - 财政年份:2010
- 资助金额:
$ 49.11万 - 项目类别:
Research Grant
Elucidation of the unusual methylenomycin biosynthetic pathway in Streptomyces coelicolor
天蓝色链霉菌中不寻常的甲霉素生物合成途径的阐明
- 批准号:
BB/E008003/1 - 财政年份:2006
- 资助金额:
$ 49.11万 - 项目类别:
Research Grant
相似国自然基金
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
- 批准号:82370751
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
- 批准号:82372202
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
- 批准号:82370885
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于甲状旁腺素重塑腱骨止点微结构及促软骨和抑瘢痕的机制研究
- 批准号:82372132
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
- 批准号:82371704
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
新生期阻断谷氨酸NMDA受体对大鼠感觉运动门控和NRG1-ErbB信号系统的影响
- 批准号:30800361
- 批准年份:2008
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
返回抑制的眼动和注意成分及其神经机制
- 批准号:30770717
- 批准年份:2007
- 资助金额:26.0 万元
- 项目类别:面上项目
相似海外基金
Using new modalities of synthetic-lethal interactions to find alternative antibacterial drug targets
使用合成致死相互作用的新模式寻找替代抗菌药物靶点
- 批准号:
10395605 - 财政年份:2020
- 资助金额:
$ 49.11万 - 项目类别:
Using new modalities of synthetic-lethal interactions to find alternative antibacterial drug targets
使用合成致死相互作用的新模式寻找替代抗菌药物靶点
- 批准号:
10203878 - 财政年份:2020
- 资助金额:
$ 49.11万 - 项目类别:
From primary target inhibition to collapse of the cell envelope biosynthetic network (A10)
从主要靶标抑制到细胞包膜生物合成网络崩溃 (A10)
- 批准号:
425789108 - 财政年份:2019
- 资助金额:
$ 49.11万 - 项目类别:
CRC/Transregios
Discovery, biosynthesis and bioactivity of phosphonic acid natural products
膦酸天然产物的发现、生物合成及生物活性
- 批准号:
10586384 - 财政年份:2018
- 资助金额:
$ 49.11万 - 项目类别:
Mechanisms of virus-mediated compartmentalization of the host translational machinery
病毒介导的宿主翻译机制区室化机制
- 批准号:
9174898 - 财政年份:2015
- 资助金额:
$ 49.11万 - 项目类别:
Mechanisms of virus-mediated compartmentalization of the host translational machinery
病毒介导的宿主翻译机制区室化机制
- 批准号:
9010465 - 财政年份:2015
- 资助金额:
$ 49.11万 - 项目类别:
Towards incorporating the biosynthetic transformation required for Striga inhibition from Desmodium into edible legume intercrops.
将独脚金抑制所需的生物合成转化纳入食用豆类间作作物中。
- 批准号:
BB/H531719/1 - 财政年份:2010
- 资助金额:
$ 49.11万 - 项目类别:
Research Grant
Towards incorporating the biosynthetic transformation required for Striga inhibition from Desmodium into edible legume intercrops
将山金钱草抑制独脚金所需的生物合成转化纳入食用豆类间作作物中
- 批准号:
BB/F003986/1 - 财政年份:2008
- 资助金额:
$ 49.11万 - 项目类别:
Research Grant
Discovery metabolite profiling of the prolyl peptidases
脯氨酰肽酶的代谢物分析的发现
- 批准号:
7938243 - 财政年份:2007
- 资助金额:
$ 49.11万 - 项目类别: